In April, the most read stories from Vascular Specialist include new data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial presented at the Leipzig Interventional Course (LINC) 2024 (28–31 May, Leipzig, Germany); recently released randomised data show cyanoacrylate glue performs strongly on patient satisfaction; Karith Foster, chief executive of Inversity Solutions, shares her thoughts ahead of headlining the Society for Vascular Surgery (SVS) Keynote Speaker Series at the 2024 Vascular Annual Meeting (VAM 2024), among several more.
1. We are not ‘and vascular’: SVS set to launch ambitious new phase in branding campaign
SVS secretary details the spirit and the cause behind the next phase of the Society’s branding campaign aimed at helping vascular surgery become an instantly recognizable specialty inside and outside of the hospital.
2. ‘Who let a vascular surgeon in the room?’: Leadership in the face of turf battles in vascular disease treatment
Leading vascular surgeons from across the globe contributed pearls of wisdom on how to go about tackling inevitable turf battles from other specialties practicing in the vascular disease space during a leadership challenges session staged by the World Federation of Vascular Societies (WFVS) at the recent 2024 Charing Cross (CX) International Symposium in London, England (April 23–25).
3. ‘What if we could translate the most durable Dacron repair into a minimally invasive approach?’
Charudatta Bavare, MD, a vascular surgeon at the Debakey Heart and Vascular Center at Houston Methodist Hospital in Houston, Texas speaks to Vascular Specialist on robotic surgery as a key part of vascular surgery’s future.
4. The devil we don’t know: The case against private equity in medicine
Editor-in-chief Malachi Sheahan III writes on private equity in vascular surgery: “I believe PE acquisitions are just a symptom of healthcare’s overall problems. Physicians are selling their practices because it is too hard to remain financially solvent on their own. Paperwork, legal requirements, electronic health records and insurance practices have all placed incredible strain on private practitioners.”
5. End of an era: Schanzer and Robinson leave legacy of VAM innovation
As this year’s Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) approaches, it marks the end of an era for Andres Schanzer, MD, and William Robinson, MD, who have played integral roles in shaping the event’s trajectory. Schanzer’s leadership as VAM program chair comes to a close after 10 years of being on the SVS Program Committee, with the last three completing his term as program chair.
6. LINC 2024: C-GUARDIANS data represent lowest event rates in published trials of CAS, TCAR and CEA
New data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial support consideration of carotid artery stenting (CAS) with the CGuard embolic prevention stent system (EPS; InspireMD) as a “frontline therapeutic option for appropriate patients being considered for carotid revascularisation”. This is according to lead investigator Chris Metzger (OhioHealth, Columbus, USA), who presented one-year results from the trial at the Leipzig Interventional Course (LINC) 2024 (28–31 May, Leipzig, Germany).
7. New randomised data show cyanoacrylate glue performs strongly on patient satisfaction
Patients undergoing cyanoacrylate glue closure for superficial venous disease reportedv higher periprocedural satisfaction than those who were treated via surgical stripping, data from a pair of randomised controlled trials (RCTs) assessing the VenaSeal system (Medtronic) reveal.
8. JVS-VL papers go under the microscope
On the final day of the 2024 International Vein Congress (April 18–20) in Miami, Florida, presenters focused on venous and lymphatics abstracts set for submission to the Journal of Vascular Surgery-Venous and Lymphatic Disorders (JVS-VL). Each presentation was then critiqued by one of the attending vascular surgeons.
9. ‘I’m a big fan of firsts’: Nationally renowned speaker on DEI set to headline new SVS keynote
Karith Foster, chief executive of Inversity Solutions, is set to headline the inaugural Society for Vascular Surgery (SVS) Keynote Speaker Series at the 2024 Vascular Annual Meeting (VAM 2024).
10. Springtime in the world of vascular training
Christopher Audu, MD, Vascular Specialist resident/fellow editor, shares programs and textbooks that might be helpful to the vascular surgical trainee and interested medical student.
